Poland starts J&J COVID-19 jabs, says benefits outweigh risks
Poland started administering Johnson & Johnson COVID-19 shots on Thursday as benefits from the vaccine outweigh potential risks, government and drug office representatives said.
U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic.
“In the case of Johnson & Johnson today is the first day it has been used.
We have not received signals that there are problems, or that patient are refusing (to take it),” Michal Dworczyk, a government official overseeing the country’s vaccine programme told a press conference.
The head of the Office for Registration of Medicinal Products told the conference that benefits from the J&J vaccine outweigh potential risks.
Read alsoIt arrived in Hungary today, but it is already being banned in America – the Janssen vaccine
please make a donation here
Hot news
National Bank of Hungary introduces HUF 50,000 coin
Ecuador’s floral wonders: The enigmatic orchids take centre stage in Budapest
Finance Minister Varga flags continued tax relief
Fidesz to modify electoral rules in Hungary – Budapest Mayor Karácsony forms harsh judgement
Hungary hosts European SME Assembly in Budapest
Attention! Traffic changes and public transport disruptions tonight in popular Budapest district
